p. 6−11
Vol.20/No.3
p. 12−19
Vol.20/No.3
0.05). The patients who used opium had a significantly higher prevalence rate of CAE (65.6% vs 35.3%; P = 0.012). Moreover, in the group with ectasia, by comparison with the non-ectatic group, significantly high levels of serum triglyceride, cholesterol, and LDL levels, as well as low HDL levels, were detected.Conclusions: Among our study population, a decrease in endocan levels was a sensitive and accurate indicator for predicting the presence of CAE, although the level of this marker was not very effective in determining the severity of ectasia. In addition to a drop in endocan expression levels, the use of opium and also an abnormal lipid profile were the other predictors of CAE.]]>
p. 20−26
Vol.20/No.3
p. 27−35
Vol.20/No.3
p. 36−46
Vol.20/No.3
p. 47−51
Vol.20/No.3
p. 52−59
Vol.20/No.3
p. 60−65
Vol.20/No.3
19.6 and a phase histogram > 72.5 in the stress phase of the examination. Several variables were evaluated using univariate and multivariate analyses. The variables significantly associated with LVD were sex (male), obesity, hypertension, diabetes, QRS > 120 ms, a history of coronary artery disease, myocardial perfusion defects reported on MPI, and LV dysfunction. Our results suggested that the prevalence of significant LVD as a predictor of adverse cardiovascular events, death, and progression to heart failure was 12.9%. The multivariate analysis revealed that variables such as obesity, diabetes, hypertension, sex (male), coronary artery disease, and QRS >120 ms were highly associated with LVD.]]>
p. 66−74
Vol.20/No.3
p. 75−83
Vol.20/No.3
p. 84−90
Vol.20/No.3
p. 91−94
Vol.20/No.3
p. 95−100
Vol.20/No.3